Y-mAbs Therapeutics Inc. (NASDAQ:YMAB)
Old Forum Content for YMAB
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- woodman: And to keep things in one place, here are other #Biotech stocks I mentioned a couple days ago. $YMAB $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX.
- Babutters: @woodman $YMAB $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX #Biotech yessir. Love the show although wasn’t impressed with the last season (if you watched the F1 season you would understand where I’m coming from). I used your list to create a new list on my YF account. Good stuff - and more studying.
- Docoof: @woodman $YMBA $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX #biotech Thank you for posting this—after hours I review all your very helpful posts. $YMBA (typo) = $YMAB.
- woodman: @Docoof $YMBA $AVXL $XNCR $NRIX $CHRS $ZNTL $OMGA $DBTX $WVE $INBX $YMAB #biotech - Thank you for the correction! Sorry I've not been so engaged the last several weeks. I've largely been taking a break during the Market malaise, attending to personal and professional matters, enjoying time with my family, and getting some golf time in as well. I am trading here and there, holding very little (currently just a few biotech or related holdings), but now trying to re-engage more so as to not be totally tuned out. Eventually, the tide will change and I don't want to be completely disengaged. But on the whole, I'm not very active in this market.
- numbers: $YMAB - ATH - yesterday - a lot of overhead pressure for 5 days, unable to breakout - just watching
| Stock Price | $8.54 |
| Change | -0.12% |
| Volume | 1,883,330 |
Y-mAbs Therapeutics Inc is a late-stage clinical biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Products developed by the company include naxitamab for the treatment of pediatric patients with relapsed or refractory and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system.
Request Video of YMABAlready a member? Sign in here.
Past Month
Leading Peers
-
$5.68 196.01%
-
$6.05 144.24%
-
$8.54 57.61%
Past Month
Lagging Peers
-
$24.95 -37.96%
-
$12.86 -32.84%
-
$5.38 -29.56%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!